Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

BACKGROUND: Incorporation of a taxane as adjuvant treatment for early breast cancer offers potential for further improvement of anthracycline-based treatment. The UK TACT study (CRUK01/001) investigated whether sequential docetaxel after anthracycline chemotherapy would improve patient outcome compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ellis, Paul, Barrett-Lee, Peter, Johnson, Lindsay, Cameron, David, Wardley, Andrew, O'Reilly, Susan, Verrill, Mark, Smith, Ian, Yarnold, John, Coleman, Robert, Earl, Helena, Canney, Peter, Twelves, Chris, Poole, Christopher, Bloomfield, David, Hopwood, Penelope, Johnston, Stephen, Dowsett, Mitchell, Bartlett, John MS, Ellis, Ian, Peckitt, Clare, Hall, Emma, Bliss, Judith M
Formato: Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2009
Materias:
Fast track — Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687939/
https://www.ncbi.nlm.nih.gov/pubmed/19447249
http://dx.doi.org/10.1016/S0140-6736(09)60740-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2687939/
https://www.ncbi.nlm.nih.gov/pubmed/19447249
http://dx.doi.org/10.1016/S0140-6736(09)60740-6

Ejemplares similares